This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Christopher Rhodes, PhD
President and CEO at Drug Delivery Experts


Dr. Rhodes is CEO and founder of Drug Delivery Experts, a contract services product development CDMO specializing in solution through complex injectables and small molecules through biologics with capabilities from formulation through clinical supplies and stability.  Dr. Rhodes is a pharmaceutical scientist with over 25 years of experience in product development of complex formulations and delivery systems including long-acting injectable, pulmonary, nasal, transdermal, and oral formulations for peptides, proteins, antibodies, oligonucleotides, and small molecules. He played a key role in the development of the commercial products Byetta, Lusedra, Bydureon, Myalept, and Afrezza, was an R&D leader at Amydis Diagnostics, SKS Ocular, Amylin, Guilford, and Mannkind, and was drug development team leader for a propofol prodrug, an NCE for peripheral neuropathy, and led translational research on delivery systems for exenatide, including nasal, pulmonary, oral, and transdermal microporation technologies.  He is a founder of Sensulin, CASS Pharmaceuticals, and Baywind Bioventures, companies developing drug delivery enabled pharmaceutical assets.  He has a PhD in chemistry (UCLA), a BS in chemistry (NYU), and was a Post Doc at Yale.

Agenda Sessions

  • Peptide Long-acting Delivery Systems